Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 365a (miR-365a) is a small non-coding RNA molecule involved in the post-transcriptional regulation of gene expression by targeting messenger RNAs for translational repression or degradation. It has key biological roles in promoting chondrocyte proliferation and differentiation by targeting HDAC4, is mechanoresponsive, and is implicated in epigenetic regulation of chromatin. miR-365a additionally regulates cardiac ion channel expression, thereby affecting cardiac electrophysiology, and altered miR-365a levels are associated with various cancers and cardiac arrhythmias. It is currently under investigation as a potential therapeutic target, particularly using inhibitory oligonucleotides in preclinical cancer models[1][2][3][4].
post-transcriptional gene silencing (binding 3'-UTR of target mRNAs), inhibition of histone deacetylase 4 (HDAC4), downregulation of repolarizing ion channels
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 365a (miR-365a).